We are live on ! Find out more
CLPT icon

ClearPoint Neuro

69 hedge funds and large institutions have $97.5M invested in ClearPoint Neuro in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $4.34M | Put options by funds: $2.99M

26% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 19

4% less capital invested

Capital invested by funds: $102M → $97.5M (-$4.58M)

1.29% less ownership

Funds ownership: 25.82%24.53% (-1.3%)

9% less funds holding

Funds holding: 7669 (-7)

35% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 17

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
69
Holders Change
-7
Holders Change %
-9.21%
% of All Funds
1.21%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
11
Increased
24
Reduced
19
Closed
17
Calls
$4.34M
Puts
$2.99M
Net Calls
+$1.34M
Net Calls Change
-$286K
Name Holding Trade Value Shares
Change
Change in
Stake
WJWM
76
Williams Jones Wealth Management
New York
-$411K -21,552 Closed
Wolverine Trading
77
Wolverine Trading
Illinois
-$384K -20,374 Closed
JF
78
Jump Financial
Illinois
-$343K -17,982 Closed
CM
79
Caption Management
Oklahoma
-$329K -17,229 Closed
Qube Research & Technologies (QRT)
80
Qube Research & Technologies (QRT)
United Kingdom
-$325K -17,019 Closed
PCM
81
Pinz Capital Management
New York
-$115K -6,000 Closed
SO
82
STRS Ohio
Ohio
-$83K -4,400 Closed
ASN
83
Advisory Services Network
Georgia
-$36K -1,860 Closed
PHK
84
Point72 Hong Kong
Hong Kong
-$17K -870 Closed
OIA
85
Optimum Investment Advisors
Illinois
-$8K -437 Closed
EI
86
Ellevest Inc
New York
+$244 +13 New

CLPT Hedge Fund Activity: Q3 2021 in Review

69 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2021, worth a combined $97.5M — down 4.5% from $102M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CLPT and 11 opened new positions — a net loss of 6 holders — while 19 trimmed existing stakes and 24 added.

The largest buyer was Royce & Associates, adding an estimated $9.82M. The largest seller was Parian Global Management, cutting an estimated $9.85M.

  • 69 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2021, down from 76 in Q2 2021.
  • Funds reported $97.5M of ClearPoint Neuro stock for Q3 2021, down 4.5% quarter-over-quarter.
  • 11 funds opened new ClearPoint Neuro positions in Q3 2021 and 17 closed out, a net change of -6 holders.
  • The largest ClearPoint Neuro buyer in Q3 2021 was Royce & Associates, an estimated $9.82M added.
  • The largest ClearPoint Neuro seller in Q3 2021 was Parian Global Management, an estimated $9.85M sold.

Based on aggregated 13F filings for Q3 2021.